Our activities are broad and aim to:
1.    Understand the disease mechanisms underlying clinical progression through the development and use of accurate laboratory models of MS, and fluid biomarker and magnetic resonance imaging (MRI) studies.
2.    Identify new treatment strategies able to slow or prevent demyelination and neurodegeneration, and promote tissue repair, in all clinical types of MS.
3.    Develop MRI techniques to aid in the accurate and timely diagnosis of MS, understand MS pathophysiology, predict clinical outcomes, and sensitively detect treatment effects in early studies of new treatments.
4.    Develop new clinical trial designs and analysis strategies to accelerate the testing of new medicines.
5.    Improve patient support, symptomatic treatment and rehabilitation, in order to reduce disability and improve well-being.
6.    Build expertise in MS research by supporting and mentoring early career investigators.
7.    Develop clinical practice through education and training opportunities for healthcare professionals in primary and secondary care.